Literature DB >> 9746607

An ex vivo study of T lymphocytes recovered from the lungs of I/St mice infected with and susceptible to Mycobacterium tuberculosis.

I Lyadova1, V Yeremeev, K Majorov, B Nikonenko, S Khaidukov, T Kondratieva, N Kobets, A Apt.   

Abstract

I/St mice, previously characterized as susceptible to Mycobacterium tuberculosis H37Rv, were given 10(3) or 10(5) CFU intravenously. At two time points postinoculation, the cell suspensions that resulted from enzymatic digestion of lungs were enumerated and further characterized phenotypically and functionally. Regarding the T-cell populations recovered at 2 and 5 weeks postinfection, two main results were obtained: (i) the population of CD44(-) CD45RB+ cells disappeared within 2 weeks postinfection, while the number of CD44(+) CD45RB-/low cells slowly increased between weeks 2 and 5; (ii) when cocultured with irradiated syngeneic splenocytes, these lung T cells proliferated in the presence of H37Rv sonicate. Using H37Rv sonicate and irradiated syngeneic splenocytes to reactivate lung T cells, we selected five CD3(+) CD4(+) CD8(-) T-cell clones. In addition to the H37Rv sonicate, the five clones react to both a short-term culture filtrate and an affinity-purified 15- to 18-kDa mycobacterial molecule as assessed by the proliferative assay. However, there was a clear difference between T-cell clones with respect to cytokine (gamma interferon [IFN-gamma] and interleukin-4 [IL-4] and IL-10) profiles: besides one Th1-like (IFN-gamma+ IL-4(-)) clone and one Th0-like (IFN-gamma+ IL-4(+) IL-10(+)) clone, three clones produced predominantly IL-10, with only marginal or no IL-4 and IFN-gamma responses. Inhibition of mycobacterial growth by macrophages in the presence of T cells was studied in a coculture in vitro system. It was found that the capacity to enhance antimycobacterial activity of macrophages fully correlated with INF-gamma production by individual T-cell clones following genetically restricted recognition of infected macrophages. The possible functional significance of cytokine diversity among T-cell clones is discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9746607      PMCID: PMC108618     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages.

Authors:  G A Rook; J Steele; M Ainsworth; B R Champion
Journal:  Immunology       Date:  1986-11       Impact factor: 7.397

2.  Distinction of virgin and memory T lymphocytes. Stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation.

Authors:  R C Budd; J C Cerottini; C Horvath; C Bron; T Pedrazzini; R C Howe; H R MacDonald
Journal:  J Immunol       Date:  1987-05-15       Impact factor: 5.422

Review 3.  Down-regulation of immune responses in the lower respiratory tract: the role of alveolar macrophages.

Authors:  P G Holt
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

4.  T cell activation by antigen-presenting cells from lung tissue digests: suppression by endogenous macrophages.

Authors:  P G Holt; A Degebrodt; C O'Leary; K Krska; T Plozza
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

5.  Mycobacterial growth inhibition by interferon-gamma-activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis.

Authors:  I Flesch; S H Kaufmann
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

6.  Human alveolar macrophages suppress the proliferative response of peripheral blood lymphocytes.

Authors:  C C McCombs; J P Michalski; B T Westerfield; R W Light
Journal:  Chest       Date:  1982-09       Impact factor: 9.410

7.  Phenotypic expression of genetically-controlled natural resistance to Mycobacterium bovis (BCG).

Authors:  J L Stach; P Gros; A Forget; E Skamene
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

8.  Role of activation in alveolar macrophage-mediated suppression of the plaque-forming cell response.

Authors:  I N Mbawuike; H B Herscowitz
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

9.  I-A restricted activation by T cell lines of anti-tuberculosis activity in murine macrophages.

Authors:  G A Rook; B R Champion; J Steele; A M Varey; J L Stanford
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

10.  A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis.

Authors:  H Groux; A O'Garra; M Bigler; M Rouleau; S Antonenko; J E de Vries; M G Roncarolo
Journal:  Nature       Date:  1997-10-16       Impact factor: 49.962

View more
  16 in total

1.  Characterization of T cell clones derived from lymph nodes and lungs of Pseudomonas aeruginosa-susceptible and resistant mice following immunization with heat-killed bacteria.

Authors:  T K Kondratieva; N V Kobets; S V Khaidukov; V V Yeremeev; I V Lyadova; A S Apt; M F Tam; M M Stevenson
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  CD4 T cells producing IFN-gamma in the lungs of mice challenged with mycobacteria express a CD27-negative phenotype.

Authors:  I V Lyadova; S Oberdorf; M A Kapina; A S Apt; S L Swain; P C Sayles
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

3.  Senescent cells expose and secrete an oxidized form of membrane-bound vimentin as revealed by a natural polyreactive antibody.

Authors:  David Frescas; Christelle M Roux; Semra Aygun-Sunar; Anatoli S Gleiberman; Peter Krasnov; Oleg V Kurnasov; Evguenia Strom; Lauren P Virtuoso; Michelle Wrobel; Andrei L Osterman; Marina P Antoch; Vadim Mett; Olga B Chernova; Andrei V Gudkov
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-13       Impact factor: 11.205

4.  Transgenic mice expressing human interleukin-10 in the antigen-presenting cell compartment show increased susceptibility to infection with Mycobacterium avium associated with decreased macrophage effector function and apoptosis.

Authors:  Carl G Feng; Marika C Kullberg; Dragana Jankovic; Allen W Cheever; Patricia Caspar; Robert L Coffman; Alan Sher
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

5.  The 19-kD antigen and protective immunity in a murine model of tuberculosis.

Authors:  V V Yeremeev; I V Lyadova; B V Nikonenko; A S Apt; C Abou-Zeid; J Inwald; D B Young
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

6.  Early emergence of CD8(+) T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice.

Authors:  N V Serbina; J L Flynn
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

7.  Proteins of the Rpf family: immune cell reactivity and vaccination efficacy against tuberculosis in mice.

Authors:  Vladimir V Yeremeev; Tatiana K Kondratieva; Elvira I Rubakova; Svetlana N Petrovskaya; Konstantin A Kazarian; Miroslav V Telkov; Sergej F Biketov; Arseny S Kaprelyants; Alexander S Apt
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

8.  Expression of L-Selectin (CD62L), CD44, and CD25 on activated bovine T cells.

Authors:  W R Waters; T E Rahner; M V Palmer; D Cheng; B J Nonnecke; D L Whipple
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

9.  Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity.

Authors:  Alissa A Chackerian; Jennifer M Alt; Thushara V Perera; Christopher C Dascher; Samuel M Behar
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

10.  Peripheral blood gamma interferon release assays predict lung responses and Mycobacterium tuberculosis disease outcome in mice.

Authors:  Gillian L Beamer; David K Flaherty; Bridget Vesosky; Joanne Turner
Journal:  Clin Vaccine Immunol       Date:  2008-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.